跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RETROVIR zidovudine 250mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
RETROVIR zidovudine 250mg capsule blister pack
Approved
STANDARD
RETROVIR zidovudine 250mg capsule blister pack
ViiV Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f8894044c958257d
Company
ViiV Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
f8894044c958257d
Product Name
RETROVIR zidovudine 250mg capsule blister pack
Artg Id
178384
Artg Name
RETROVIR zidovudine 250mg capsule blister pack
Sponsor
ViiV Healthcare Pty Ltd
Company Detail Path
/organization/viiv-healthcare-pty-ltd
Artg Date
2011-03-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b1ff6532c7924e21148a0402164e22fc.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4af59cc3d9f2dddec52bc086e69f5dc7.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f8894044c958257d
Type
Standard
Back to TGA Approvals